Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hypertension
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hypertension
    Obesity Leading Risk Factor of Left Atrial Enlargement During Aging - (DGNews)
    TopAbstracts in Hypertension 11/25/2009 - (DGNews)
    Team-Based Care Involving a Pharmacist Improves Blood Pressure Control - (DGNews)
    Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study - (BMJ)
    TopAbstracts in Hypertension 11/18/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Hypertension
    • State of the Art in Pulmonary Arterial Hypertension
    • Medication Use for Diabetes, Hypertension, and Hypercholesterolemia from 1988-1994 to 2001-2006
      Optimizing Antihypertensive Therapy and Health and Economic Outcomes in a Managed Care Environment
      Treating Coronary Artery Disease in Vulnerable Adults
      Thrombotic Thrombocytopenic Purpura: The Masquerader

      Webcasts/CME archive

       Recent cases - Hypertension
        A Woman with Swollen Fingers and New-Onset Hypertension and Renal Failure
        Hypertension
        Medical Management of a Pregnancy Woman with Moderate Renal Insufficiency and Superimposed Preclampsia
        Malignant Hypertension and Acute Aortic Dissection Associated with Caffeine-Based Ephedra-Free Dietary Supplements: A Case Report
        Giant Right Coronary Artery Aneurysm: Case Report and Literature Review

        Cases archive
          




        my personal edition > hypertension > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Amlodipine's Antihypertensive Effect Persists Longer Than Nifedipine Gastrointestinal Therapeutic System After Missed Doses

        A DGReview of :"Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': a randomised, double-blind comparative trial in Asian patients."
        Journal of Human Hypertension

        02/03/2003
        By James Adams


        Amlodipine provides more persistent blood pressure control than does nifedipine gastrointestinal therapeutic system (GITS) following missed doses.

        Missed doses of antihypertensive medication are often the cause of suboptimal management of hypertension, explain investigators from St. Luke's Medical Centre in Quezon City in the Philippines. They conducted a multi-centre, randomized, double-blind, parallel-group study comparing the persistence of amlodipine and nifedipine GITS after two missed doses in 222 Asian patients with mild to moderate hypertension.

        Patients received either 5 milligrams of amlodipine or 30 milligrams nifedipine GITS daily for six weeks. Doses of each medication were doubled after six weeks if necessary for blood pressure control. Treatment continued for 12 weeks.

        Mean 24-hour ambulatory blood pressure levels were similar in both groups on the last day of treatment.

        After the 12-week treatment period, placebo was substituted for both medications for two days, and the effect on ambulatory blood pressure was monitored.

        Results showed significant differences in mean ambulatory blood pressure between the amlodipine and nifedipine GITS groups on the first day of treatment withdrawal.

        Increases in mean ambulatory blood pressure during the last nine hours of the second day of placebo administration were significantly lower in the amlodipine group.
        J Hum Hypertens 2002;16:11:805-813. "Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': a randomised, double-blind comparative trial in Asian patients."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send